Table 4. Scores and Clinical Information on Organ Support.
Day 1 | Day 2 | Day 3 | Day 4 | ||
---|---|---|---|---|---|
SOFA | Control | 10.6 ±1.2 | 9.8 ±1.4 | 10.1 ±1.4 | 9.5 ±1.6 |
IgM-IVIg | 11.7 ±0.9 | 10.3 ±0.8 | 9.4 ±1.2 | 7.0 ±1.8 | |
Vasopressor Therapy [n (%)] | Control | 13 (92.8) | 11 (78.6) | 10 (71.4) | 8 (57.1) |
IgM-IVIg | 10 (83.3) | 10 (83.3) | 5 (45.4) | 4 (40.0) | |
Mechanical Ventilation [n (%)] | Control | 13 (92.8) | 13 (92.8) | 11 (78.6) | 11 (78.6) |
IgM-IVIg | 12 (100.0) | 10 (83.3) | 8 (72.7) | 6 (60.0) | |
Dialysis [n (%)] | Control | 5 (35.7) | 7 (50.0) | 9 (64.3) | 9 (64.3) |
IgM-IVIg | 4 (33.3) | 4 (33.3) | 5 (45.4) | 4 (40.0) |
SOFA, Sequential Organ Failure Assessment; IgM-IVIg, IgM-enriched intravenous immunoglobulin; Control group n = 14, IgM-IVIg group n = 12 (day 1 and 2), n = 11 (day 3) and n = 10 (day 4); no significant differences between the groups were detected using the Students’ t-test or Fisher Exact test